Skip to main content
. 2020 Sep 21;47(1):54–63. doi: 10.1093/schbul/sbaa084

Fig. 2.

Fig. 2.

Differences in medication use, symptoms, and cognition between 4 negative symptom-based clusters in a clinical high-risk sample. (A) The percent of antipsychotic and selective serotonin reuptake inhibitor (SSRI) medications taken in each cluster group. (B) The total sum score of disorganized, general, and positive symptoms from the Structured Interview for Psychosis-Risk Syndromes (SIPS). (C) Total sum scores from the Beck Depression Inventory (denoted as “Depression”) and the Beck Anxiety Inventory (represented as “Anxiety”). (D) Cognitive scores are reflected as correct t-scores. Error bars represent standard error.